Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Invested Capital (2016 - 2025)

Historic Invested Capital for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Pediatrix Medical's Invested Capital fell 355.2% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 355.2%. This contributed to the annual value of $1.4 billion for FY2024, which is 646.54% down from last year.
  • According to the latest figures from Q3 2025, Pediatrix Medical's Invested Capital is $1.1 billion, which was down 355.2% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Invested Capital registered a high of $1.9 billion during Q4 2021, and its lowest value of $767.0 million during Q1 2021.
  • In the last 5 years, Pediatrix Medical's Invested Capital had a median value of $1.3 billion in 2024 and averaged $1.2 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first tumbled by 4843.45% in 2021, then surged by 6650.64% in 2022.
  • Over the past 5 years, Pediatrix Medical's Invested Capital (Quarter) stood at $1.9 billion in 2021, then decreased by 18.95% to $1.5 billion in 2022, then fell by 3.77% to $1.5 billion in 2023, then decreased by 6.47% to $1.4 billion in 2024, then fell by 20.63% to $1.1 billion in 2025.
  • Its Invested Capital stands at $1.1 billion for Q3 2025, versus $1.0 billion for Q2 2025 and $1.0 billion for Q1 2025.